Person

Daniel J. Lippis

CVP, TAVR, Edwards Lifesciences

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$2.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 8, 2026EWSale619$85.65$53K
Sep 11, 2026EWSale619$87.51$54K
Aug 11, 2026EWSale619$92.03$57K
Jul 10, 2026EWSale619$91.70$57K
Jun 30, 2026EWSale619$91.40$57K
May 18, 2026EWSale620$81.14$50K
May 4, 2026EWSale1,019$83.98$86K
May 1, 2026EWSale19$83.99$2K
May 1, 2026EWSale1,000$82.99$83K
Apr 6, 2026EWSale1,019$80.98$83K
Mar 11, 2026EWSale1,019$85.38$87K
Jan 9, 2026EWSale1,019$85.70$87K
Dec 12, 2025EWSale1,019$84.03$86K
Nov 10, 2025EWSale1,020$82.55$84K
Jul 28, 2025EWSale4,114$79.46$327K
May 9, 2025EWSale330$74.42$25K
Apr 8, 2025EWSale300$70.61$21K
Mar 10, 2025EWSale400$69.48$28K
Feb 13, 2025EWSale500$76.34$38K
Jan 16, 2025EWSale500$68.76$34K
Dec 16, 2024EWSale2,500$74.08$185K
Jul 11, 2024EWSale500$94.18$47K
Jun 20, 2024EWSale535$90.00$48K
May 7, 2024EWSale857$85.60$73K
Apr 9, 2024EWSale857$92.34$79K
Mar 7, 2024EWSale1,715$90.98$156K

SEC reporting-owner ID (CIK) 2004380 · all filings on EDGAR